Skip to content
healthcare.dev
Get a free key

CETIRIZINE HYDROCHLORIDE

NDC 70752-103, CETIRIZINE HYDROCHLORIDE, solution, from QUAGEN PHARMACEUTICALS LLC.

Product NDC
70752-103
Status
Listed
Labeler
QUAGEN PHARMACEUTICALS LLC
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA212266
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70752-103 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE1 mg/mL

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
70752-103-06707520103061 BOTTLE, PLASTIC in 1 CARTON (70752-103-06) / 118 mL in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 70752-103 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70752-103 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70752-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.